← All stories
Markets

Oxford (LSE:OCTP) — Why Is Clinical Development So Different From The Rest Of Cannabis Trade?

1 source ·1 article ·1h ago

Highlights Cannabinoid pharmaceutical development follows conventional regulatory pathways rather than wellness product routes. The London-quoted plant medicine cohort remains micro-cap and funding-constrained. Clinical programme milestones…

Covered by 1 outlet

All coverage · 1 article